{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-171917","form_type":"8-K","ticker":"ACAD","cik":"0001070494","company_name":"ACADIA PHARMACEUTICALS INC","filed_at":"2022-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.622514+00:00","generated_at":"2026-06-25T02:36:53.940741+00:00","sec_items":["5.02","5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Acadia stockholders approve 6M share increase for equity plan, elect directors","bullets":["Stockholders approved amendment to 2010 Equity Incentive Plan, increasing authorized shares by 6,000,000 (135.2M for, 6.6M against).","Class III directors Laura A. Brege, Stephen R. Davis, and Elizabeth A. Garofalo elected with 89.4M, 127.1M, and 117.4M votes for, respectively.","Advisory vote on executive compensation approved (127.2M for, 3.4M against).","Ratification of Ernst & Young as independent auditor for FY2022 passed (141.5M for)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-171917","json":"https://secwatch.observer/filing/0001193125-22-171917.json","markdown":"https://secwatch.observer/filing/0001193125-22-171917.md","text":"https://secwatch.observer/filing/0001193125-22-171917.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/0001193125-22-171917-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1070494/000119312522171917/d364504d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T02:36:53.940741+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}